Sparsentan 400MG tab QTY 30 with 7 refills
Ended Awarded Last action
- Contract number
- 36C26124N0539
- Awardee
-
Travere Therapeutics, Inc. UEI JUBZMHK84S36
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,771
Award facts
- Contract value 100% obligated
- $36,771.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,709 | |
| Original award | $51,480 |
About this award
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract provides for the supply of 30 tablets of Sparsentan 400mg, with 7 refills, at a ceiling value of $36,771.30. The order is issued against Travere's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which has a total potential value of up to $14,970,593.10. Travere also holds two $25 million Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center for the procurement of its specialized drugs Thiola and Cholbam. This federal contract award, with a performance period ending in May 2024, supports the VA's mission to provide healthcare services to over 9 million enrolled veterans. The contract does not utilize any set-aside designations.
Quick answers
Who was awarded contract 36C26124N0539?
36C26124N0539 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 21, 2024.
How much is contract 36C26124N0539 worth?
The government has obligated $36,771 on 36C26124N0539.
Is contract 36C26124N0539 an order under another contract?
Yes. 36C26124N0539 is a delivery order under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0539 competed?
The extent of competition for 36C26124N0539 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award